Global Cord Blood (CO) Competitors $1.00 +0.10 (+11.11%) As of 09/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock CO vs. CORBF, MRAI, ZVRA, PRME, AGL, LAB, BCYC, EOLS, REPL, and CMPSShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Global Cord Blood (CORBF), Marpai (MRAI), Zevra Therapeutics (ZVRA), Prime Medicine (PRME), Agilon Health (AGL), Standard BioTools (LAB), Bicycle Therapeutics (BCYC), Evolus (EOLS), Replimune Group (REPL), and COMPASS Pathways (CMPS). Global Cord Blood vs. Its Competitors Global Cord Blood Marpai Zevra Therapeutics Prime Medicine Agilon Health Standard BioTools Bicycle Therapeutics Evolus Replimune Group COMPASS Pathways Global Cord Blood (NYSE:CORBF) and Global Cord Blood (NYSE:CO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership. Which has stronger earnings & valuation, CORBF or CO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$196.12M0.62$79.04MN/AN/AGlobal Cord Blood$1.24B0.10$79.04M$0.641.56 Which has more risk & volatility, CORBF or CO? Global Cord Blood has a beta of -0.59, indicating that its share price is 159% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500. Is CORBF or CO more profitable? Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A Global Cord Blood N/A N/A N/A Does the media refer more to CORBF or CO? In the previous week, Global Cord Blood's average media sentiment score of 0.00 equaled Global Cord Blood'saverage media sentiment score. Company Overall Sentiment Global Cord Blood Neutral Global Cord Blood Neutral SummaryGlobal Cord Blood beats Global Cord Blood on 2 of the 3 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CO vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$121.55M$88.00M$5.80B$21.52BDividend YieldN/AN/A5.72%3.50%P/E Ratio1.560.7875.0529.84Price / Sales0.100.44544.0070.86Price / Cash4.192.8025.8118.13Price / Book0.160.1613.434.65Net Income$79.04M$43.11M$3.29B$999.94M7 Day Performance-4.76%-4.24%0.08%1.08%1 Month PerformanceN/A49.22%4.61%4.53%1 Year Performance-33.33%23.53%75.02%14.39% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COGlobal Cord BloodN/A$1.00+11.1%N/A-33.3%$121.55M$1.24B1.561,202Gap DownCORBFGlobal Cord BloodN/A$1.05flatN/A-33.3%$127.63M$196.12M0.001,200Gap DownMRAIMarpaiN/A$1.28-4.5%N/A+137.3%$23.14M$34.87M-0.48150Gap DownZVRAZevra Therapeutics2.9987 of 5 stars$8.33-6.9%$23.71+184.7%-7.9%$502.41M$23.61M-39.6720Analyst DowngradePRMEPrime Medicine3.2941 of 5 stars$3.89+4.6%$8.92+129.2%-2.0%$500.62M$4.96M-1.90234Gap UpAGLAgilon Health2.6903 of 5 stars$1.26+4.6%$3.07+144.7%-68.4%$497.31M$6.06B-1.631,076LABStandard BioTools2.8379 of 5 stars$1.36+4.6%$1.55+14.0%-33.5%$496.59M$174.43M-4.25620Positive NewsHigh Trading VolumeBCYCBicycle Therapeutics3.507 of 5 stars$7.00-2.2%$22.22+217.5%-74.6%$495.86M$35.28M-1.99240Positive NewsEOLSEvolus4.0518 of 5 stars$7.61-0.7%$21.25+179.2%-62.1%$495.49M$266.27M-7.77170Positive NewsREPLReplimune Group3.9654 of 5 stars$6.04-4.6%$6.50+7.6%-49.1%$494.09MN/A-1.86210CMPSCOMPASS Pathways3.2503 of 5 stars$4.98-3.1%$16.29+227.0%-29.1%$493.14MN/A-2.71120Positive News Related Companies and Tools Related Companies CORBF Competitors MRAI Competitors ZVRA Competitors PRME Competitors AGL Competitors LAB Competitors BCYC Competitors EOLS Competitors REPL Competitors CMPS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CO) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CO Stock Alerts